Categories: CancerNewsVeterans

Scientific Peer Review of Congressionally Directed Medical Research Programs’ Peer Reviewed Cancer Research Program for the Department of Defense

FORT DETRICK, Md., Nov. 03, 2022 (GLOBE NEWSWIRE) — The Congressionally Directed Medical Research Programs’ (CDMRP), Peer Reviewed Cancer Research Program (PRCRP) consumer advocate recently participated in the evaluation of research applications submitted to the PRCRP. Paul Gater was nominated for participation in the program by The International Myeloma Foundation (IMF), Los Angeles, CA. As a consumer reviewer, Paul was a full voting member, (along with prominent scientists) at meetings to help determine how the $130 million appropriated by Congress for Fiscal Year 2022 will be spent on peer reviewed cancer research.

Consumer reviewers are asked to represent the collective view of patients by preparing comments on the impact of the research on issues such as diagnosis, treatment, and quality of life. When commenting on serving as a consumer reviewer, Paul said that, “This was a wonderful opportunity to be a voice for the multiple myeloma patient community in reviewing applications for research funding. I’m grateful to the IMF for nominating me to be part of this important review process.”

Consumer advocates and scientists have worked together in this unique partnership to evaluate the merit of research applications since FY09. COL Sarah B. Goldman, Director of the CDMRP, expressed her appreciation for the consumer advocates’ hard work. “Integrating consumer perspectives into our decision-making process brings energy and focus to our research programs. Patients, caregivers, family members, and advocates help us keep our efforts centered around what is truly important to those impacted. We very much value this critical input from our consumers who help ensure that CDMRP’s work remains critical and relevant,” she said.

Researchers applying to the PRCRP propose to advance mission readiness of U.S. military members affected by cancer and to improve quality of life by decreasing the burden of cancer on Service members, their families, Veterans, and the American public.

More information about the CDMRP PRCRP is available at the website: https://cdmrp.health.mil/PRCRP/default.

_______
Media Contact:

Hayley Gula
Public Affairs Specialist
Congressionally Directed Medical Research Programs
U.S. Army Medical Research and Development Command
1077 Patchel St, Fort Detrick, MD 21702
Office Phone: 301-619-4342
Cell Phone (Work): 240-344-6007
Email: hayley.m.gula.civ@mail.mil

Staff

Recent Posts

Best GLP-1 Weight Loss Shot (2026): Direct Meds Reviews Prescription Access Pathways as New GLP-1 Formats Expand

LegitScript-certified telehealth platform publishes consumer analysis as searches for GLP-1 weight loss information reach record…

2 hours ago

Nutri Derma Guard Skin Tag Remover Ingredients Investigated: 2026 Analysis Examines Formulation And Consumer Disclosures

Independent investigation examines castor oil, tea tree oil, and salicylic acid formulation claims in the…

2 hours ago

SleepZee Mouth Guard Legitimacy Examined: 2026 Consumer Analysis Investigates Anti-Snoring Device Claims and Company Transparency

Independent examination investigates SleepZee's moldable customization approach, medical-grade material claims, and manufacturer disclosure practices for…

2 hours ago

Calm Nature CBD Gummies Ingredients: 2026 Consumer Analysis Examines Full Spectrum CBD Claims, Testing Standards, and Formulation Transparency

Independent report examines Calm Nature CBD Gummies full spectrum formulation, CO2 extraction claims, THC removal…

2 hours ago